News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer Yakuhin Ltd. Has Legionella Infection Indication Approved For Its New Quinolone Antibacterial Agent Ciproxan



2/27/2006 2:20:31 PM

Tokyo, Feb 27, 2006 (JCN) - Bayer Yakuhin announced on February 24 that it has obtained additional approval for Ciproxan Injection/Tablet, its proprietary new-quinolone agent, from the Ministry of Health, Labor and Welfare. Ciproxan is now available in the treatment of infections caused by Legionella bacteria including Legionella pneumonia.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES